Therapeutic Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Lung Injury Mice

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Zhu, Hua ^a,b   Xiong, Yi ^a   Xia, Yunqiu ^a   Zhang, Rong ^a   Tian, Daiyin ^a   Wang, Ting ^a   Dai, Jihong ^a   Wang, Lijia ^a   Yao, Hongbing ^a   Jiang, Hong ^b   Yang, Ke ^a,c   Liu, Enmei ^a   Shi, Yujun ^d   Fu, Zhou ^a,c   Gao, Li ^a,c   Zou, Lin ^a,c  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c Chongqing Stem Cell Therapy Engineering and Technology Center   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ACUTE LUNG INJURY; ANIMAL; BAGG ALBINO MOUSE; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; FEMALE; HUMAN; LUNG; MACROPHAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MORTALITY; MOUSE; PATHOLOGY; SURVIVAL RATE; UMBILICAL CORD;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SURVIVAL RATE; UMBILICAL CORD;

EID: 85008323993     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39889     Document Type: Article

References (45)

1. Force, A. D. T. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526-2533 (2012).
2. Han, S. et al. The acute respiratory distress syndrome: from mechanism to translation. J Immunol 194, 855-860 (2015).
3. Phua, J. et al. Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med 179, 220-227 (2009).
4. Rubenfeld, G. D. et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353, 1685-1693 (2005).
5. Antunes, M. A. et al. Mesenchymal stem cell trials for pulmonary diseases. J Cell Biochem 115, 1023-1032 (2014).
6. Lv, F. J. et al. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem cells 32, 1408-1419 (2014).
7. Akram, K. M. et al. Mesenchymal stem cell therapy and lung diseases. Adv Biochem Eng Biotechnol 130, 105-129 (2013).
8. Panepucci, R. A. et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem cells 22, 1263-1278 (2004).
9. Li, G. et al. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics 9, 20-30 (2009).
10. Lee, M. et al. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo. Biochem Biophys Res Commun 446, 983-989 (2014).
11. El Omar, R. et al. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev 20, 523-544 (2014).
12. Moodley, Y. et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 175, 303-313 (2009).
13. Liu, L. et al. Intranasal versus intraperitoneal delivery of human umbilical cord tissue-derived cultured mesenchymal stromal cells in a murine model of neonatal lung injury. Am J Pathol 184, 3344-3358 (2014).
14. Tang, Y. L. et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104, 1209-1216 (2009).
15. Bowman, C. C. et al. Cyclooxygenase-2-Mediated Prostaglandin E2 Production in Mesenteric Lymph Nodes and in Cultured Macrophages and Dendritic Cells after Infection with Salmonella. J Immunol 172, 2469-2475 (2004).
16. Trune, D. R. et al. Simultaneous measurement of multiple ear proteins with multiplex ELISA assays. Hear Res 275, 1-7 (2011).
17. Xie, G. et al. p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation. Molecules 17, 8159-8173 (2012).
18. Rajaiah, R. et al. Dissociation of Endotoxin Tolerance and Differentiation of Alternatively Activated Macrophages. J Immunol 190, 4763-4772 (2013).
19. Hoegl S, B. K. et al. Inhaled IL-10 reduces biotrauma and mortality in a model of ventilator-induced lung injury. Respir Med 103, 463-470 (2009).
20. Inamdar, A. C. et al. Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell. Exp Lung Res 39, 315-327 (2013).
21. Kalinski, P. Regulation of immune responses by prostaglandin E2. J Immunol 188, 21-28 (2012).
22. Ylostalo, J. H. et al. Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem cells 30, 2283-2296 (2012).
23. Nemeth, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15, 42-49 (2009).
24. Arthur, P. & Wheeler, G. R. B. Acute lung injury and the acute respiratory distress syndrome:a clinical review. Lancet 369, 1553-1565 (2007).
25. Sheu, C. C. et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest 138, 559-567 (2010).
26. Shi, D. et al. Protective effects and mechanisms of mogroside V on LPS-induced acute lung injury in mice. Pharm Biol 52, 729-734 (2014).
27. Chen, H., B. C. et al. The value of the lipopolysaccharide induced acute lung injury. Expert Rev Respir Med 4, 773-783 (2010).
28. Monsel, A, Z. Y. et al. Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. Am J Respir Crit Care Med 192, 324-336 (2015).
29. Rojas, M. et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33, 145-152 (2005).
30. Kotton, D. N., M., B. et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128, 5181-5188 (2001).
31. Kawai, T. et al. Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration. Cytotherapy 17, 369-381 (2015).
32. Waszak, P. et al. Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats. Stem Cells and Dev 21, 2789-2797 (2012).
33. Zhang, Y. et al. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348, aaa2340 (2015).
34. Hiroshima, Y. et al. S100A8 induces IL-10 and protects against acute lung injury. J Immunol 192, 2800-2811 (2014).
35. Hamilton, J. A. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8, 533-544 (2008).
36. Steinwede, K. et al. Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia. J Immunol 187, 5346-5356 (2011).
37. Mathias, B. et al. A Review of GM-CSF Therapy in Sepsis. Medicine (Baltimore) 94, e2044 (2015).
38. Dittrich, A. et al. Systems biology of IL-6, IL-12 family cytokines. Cytokine Growth Factor Rev 26, 595-602 (2015).
39. Zhang, Q. Z. et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem cells 28, 1856-1868 (2010).
40. Martinez, F. O. et al. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27, 451-483 (2009).
41. Aggarwal, N. R. et al. Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol 306, L709-725 (2014).
42. Salazar, K. D. et al. Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 297, L1002-1011 (2009).
43. Choi, H. et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 118, 330-338 (2011).
44. Francois, M. et al. Human MSC suppression correlates with cytokine induction of indoleamine 2, 3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20, 187-195 (2012).
45. Zheng, G. et al. Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization. Stem Cells Int 2015, 989473 (2015).